C Partners Holding’s Adamas Pharmaceuticals ADMS Stock Holding History

C Partners Holding’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-59,273	Closed	-$973K	–	16
2016 Q3	$973K	Sell	59,273 -577,855	-91%	-$8.78M	0.4%	14
2016 Q2	$9.65M	Sell	637,128 -200,000	-24%	-$3.3M	3.92%	9
2016 Q1	$12.1M	Hold	837,128	–	–	5.99%	5
2015 Q4	$23.7M	Sell	837,128 -475,000	-36%	-$8M	13.09%	3
2015 Q3	$22M	Sell	1,312,128 -162,354	-11%	-$3.69M	12.12%	3
2015 Q2	$38.7M	Sell	1,474,482 -187,646	-11%	-$3.65M	18.12%	2
2015 Q1	$29M	Sell	1,662,128 -350,000	-17%	-$6M	9.28%	2
2014 Q4	$35M	Buy	+2,012,128	New	+$30.5M	11.33%	2

Other funds holding ADMS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BWCA

Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

C Partners Holding's ADMS Position: Q4 2016 in Review

C Partners Holding sold out of Adamas Pharmaceuticals (ADMS) in Q4 2016, closing a stake of 59,273 shares — an estimated $973K sold.

C Partners Holding first reported a position in ADMS in Q4 2014 and held it in 8 quarters. The position peaked at $38.7M in Q2 2015. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

C Partners Holding reported no remaining Adamas Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
C Partners Holding sold 59,273 Adamas Pharmaceuticals shares in Q4 2016, an estimated $973K.
C Partners Holding first reported a position in Adamas Pharmaceuticals in Q4 2014 and held it in 8 quarters.
C Partners Holding's Adamas Pharmaceuticals position peaked at $38.7M in Q2 2015.
78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on C Partners Holding's 13F filing for Q4 2016, filed 14 Feb 2017.